U.S. Pharma Stock News

In early May 2026, Blackstone Mortgage Trust, Inc. launched a private offering of US$450 million in senior secured 6.250% notes due 2031, intending to use the proceeds for general corporate purposes, including repaying existing secured debt. This debt raise follows a first-quarter 2026 result where revenue roughly doubled year on year but the company still reported a net loss of US$6.3 million, highlighting how its funding choices intersect with a shifting earnings profile. Next, we’ll...

Ralph Lauren stock: performance snapshot and business mix Ralph Lauren (RL) is back on investor radar after recent share price moves, with the stock closing at $353.55 and showing mixed short term performance alongside strong multi year total returns. Over the past day and week, Ralph Lauren has recorded returns of 5.0% decline and 1.4% decline, while the stock shows gains of 1.2% over the past month and 3.1% over the past 3 months. Year to date the stock is down 2.5%. Its 1 year, 3 year, and...

If you are wondering whether Northrop Grumman at around US$552.27 is offering fair value today, it helps to break the story into recent returns, current sentiment and what the numbers say about price versus fundamentals. The stock has had a mixed run, with a 4.7% decline over the last week and a 20.0% decline over the last month, yet it still shows a 15.9% return over 1 year, 33.2% over 3 years and 61.8% over 5 years. Recent coverage of the defense sector has focused on ongoing geopolitical...

In the first quarter ended March 31, 2026, Stoke Therapeutics reported sales of US$6.23 million versus US$158.57 million a year earlier, shifting from net income of US$112.88 million to a net loss of US$50 million and reporting basic and diluted loss per share of US$0.79 from continuing operations. Against this backdrop, recent insider activity, including Chief Medical Officer Barry Ticho’s Rule 10b5-1-planned sale of 2,243 shares, leaving him with 36,621 shares, adds an additional lens on...

Otis Worldwide (NYSE:OTIS) has named co-champions in its latest "Made to Move Communities" student challenge. The winning teams focused on STEM and AI concepts designed to support vulnerable communities during natural disasters. The program highlights student projects that address real-world mobility and access issues in crisis situations. Otis Worldwide, best known for elevators, escalators and related services, is using this global challenge to connect its core focus on mobility with...

Why Herc Holdings' latest earnings are drawing attention Herc Holdings (HRI) released first quarter 2026 results that show higher sales and revenue alongside a wider net loss and higher loss per share, a mix that helps explain recent stock interest. See our latest analysis for Herc Holdings. Herc Holdings' first quarter 2026 update has landed against a backdrop of sharp share price swings, with a 40.1% 1 month share price return following a 26.9% 3 month share price decline. The 1 year total...

As you might know, Vericel Corporation ( NASDAQ:VCEL ) just kicked off its latest quarterly results with some very...

As you might know, Duke Energy Corporation ( NYSE:DUK ) just kicked off its latest first-quarter results with some very...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Arrow...

Investors were disappointed with The Marcus Corporation's ( NYSE:MCS ) earnings, despite the strong profit numbers. We...

Roper Technologies, Inc.'s ( NASDAQ:ROP ) robust recent earnings didn't do much to move the stock. We believe that...

In recent months, Chewy has broadened its higher-margin healthcare and private-label offerings, including acquiring veterinary clinic operator Modern Animal to expand its pet health footprint. This push into services and owned brands marks a shift in Chewy’s business mix that could be increasingly important for its long-term profitability profile. We’ll now examine how Chewy’s expansion into veterinary services and healthcare could influence its existing investment narrative and future...

Devon Energy, NYSE:DVN, has completed its all stock merger with Coterra Energy, creating a larger US shale operator with expanded inventory. Alongside the deal closing, the company announced an $8b share repurchase authorization. Devon also declared a 33% dividend increase as part of a broader capital return program. For investors tracking NYSE:DVN, the merger comes at a time when the stock is trading around $45.31, with a 1 year return of 45.6% and a 5 year return of 135.6%. These figures...

Datadog (DDOG) opened Q1 2026 with revenue of US$1.0 billion and basic EPS of US$0.15, alongside net income of US$52.6 million, setting the tone for how investors read the latest print against its recent history. The company has seen quarterly revenue move from US$737.7 million in Q4 2024 to US$1.0 billion in Q1 2026, while basic EPS has ranged from US$0.13 to US$0.15 over the same span. This gives a clear view of how the top and bottom lines are tracking as margins remain a key lens on the...

In recent weeks, Intel announced that Alex Katouzian will join as executive vice president and general manager of the Client Computing and Physical AI Group, while Pushkar Ranade has been appointed chief technology officer to steer long‑term bets in quantum, neuromorphic computing, photonics, and novel materials. These leadership moves deepen Intel’s focus on “physical AI” and advanced research areas, tightening the link between its technology roadmap and emerging AI hardware opportunities...

Wondering if Viper Energy's current price really reflects its potential value, or if the stock might offer more than the market is giving it credit for right now. The stock closed at US$46.98, with a 21.3% return over the last year and 21.1% year to date, although the past week saw a 4.9% decline and the past month was flat at 0.0%. Recent coverage has focused on Viper Energy's role in the US energy sector and how investors are weighing its income profile against commodity price movements...

Clearwater Analytics Holdings (CWAN) closed out FY 2025 with Q4 revenue of US$217.5 million and a basic EPS loss of US$0.04, as net income excluding extra items came in at a loss of US$12.1 million. Over recent periods the company has seen quarterly revenue move from US$126.5 million in Q4 FY 2024 to US$217.5 million in Q4 FY 2025, while basic EPS shifted from US$1.85 a share in Q4 FY 2024 to a loss of US$0.04 a share in the latest quarter. This sets up a results season in which investors are...

If you are wondering whether Ferguson Enterprises at around US$246.53 is still worth your attention, it helps to start by separating price moves from underlying value. The stock has seen a 7.9% decline over the last 7 days, set against returns of 4.5% over 30 days, 9.6% year to date, 46.3% over 1 year, 78.6% over 3 years and 109.5% over 5 years. This naturally raises questions about how much future strength or risk is already reflected in the price. Recent coverage of Ferguson Enterprises...

MNTN, Inc. recently reported first-quarter 2026 results, with sales rising to US$73.67 million and net income improving to US$8.76 million, reversing a net loss a year earlier and lifting basic earnings per share from continuing operations to US$0.12. On the same day, the company launched QuickFrame AI 3.0, expanding its AI-powered creative platform into a full production workflow that lets brands rapidly generate, edit, and publish multi-format video ads across major digital and TV...

Insmed (INSM) opened Q1 2026 with revenue of US$306 million and a basic EPS loss of US$0.76, while the trailing twelve months show revenue of US$820 million and a basic EPS loss of US$5.70. Over the past reported quarters, revenue has moved from US$93 million in Q1 2025 to US$306 million in Q1 2026, alongside quarterly basic EPS losses ranging between US$0.76 and US$1.75. This keeps the focus squarely on how efficiently new sales translate into narrowing losses. For investors, the story this...

Affirm Holdings (AFRM) opened its Q2 2026 update with total revenue of US$1.1b and basic EPS of US$0.39, alongside trailing twelve month revenue of US$3.7b and EPS of US$0.86 that put profitability firmly in focus. The company has seen quarterly revenue move from US$866.4m in Q2 2025 to US$1.1b in Q2 2026, while basic EPS shifted from US$0.25 to US$0.39 over the same period. This sets up this print as a key checkpoint on whether margins are starting to scale more consistently. See our full...

Curious whether Luckin Coffee at US$33.44 is giving you real value or just headline noise? This article breaks down what the current price might be implying about the stock. The stock has been choppy recently, with a 4.5% decline over the last week, a 2.9% gain over the last 30 days, a 5.6% year to date decline, and a 2.9% return over the last year, on top of a 65.2% return over three years and a very large gain over five years. Recent coverage of Luckin Coffee has focused on its position in...

Wondering whether Intuitive Machines stock still offers value after its recent volatility, or if you might be turning up late to the story? The stock closed at US$24.11, with a 4.9% decline over the last 7 days, a 6.1% gain over 30 days, a 34.8% return year to date, and a 157.9% return over the past year. Recent headlines around Intuitive Machines have kept the stock in focus, with investors paying closer attention to how its projects translate into long term potential. This context helps...

eXp World Holdings (AGNT) recently drew attention after eXp Commercial added veteran broker Mario J Alvarez Jr, whose two decades in commercial real estate align with the company’s effort to grow its investment sales presence. See our latest analysis for eXp World Holdings. At a share price of $6.60, eXp World Holdings has a 30 day share price return of 10.18% and a 7 day gain of 2.48%. However, the year to date share price return of 27.47% and 90 day share price return of 23.79% point to...